Guidance A-Z — V
56 guidance documents beginning with V.
VA ECMO for extracorporeal cardiopulmonary resuscitation (ECPR) in adults with refractory cardiac arrest
VA ECMO for postcardiotomy cardiogenic shock in adults
VA ECMO for severe acute heart failure in adults
VAAFT for treating anal fistulae
Vaccine uptake in the general population
Vaccine uptake in under 19s
Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease
Vaginal transluminal endoscopic hysterectomy and adnexal surgery for benign gynaecological conditions
Valve-in-valve TAVI for aortic bioprosthetic valve dysfunction
Vamorolone for treating Duchenne muscular dystrophy in people 4 years and over
Vandetanib for treating medullary thyroid cancer
Vanzacaftor-tezacaftor-deutivacaftor for treating cystic fibrosis with 1 or more F508del mutations in the CFTR gene in people 6 years and over
Varenicline for smoking cessation
Varicose veins in the legs
Varicose veins: diagnosis and management
Vedolizumab for treating chronic refractory pouchitis after surgery for ulcerative colitis (terminated appraisal)
Vedolizumab for treating moderately to severely active Crohn's disease after prior therapy
Vedolizumab for treating moderately to severely active ulcerative colitis
Velmanase alfa for treating alpha-mannosidosis
Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation‑positive malignant melanoma
Venetoclax for treating chronic lymphocytic leukaemia
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable
Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia
Venetoclax with rituximab for previously treated chronic lymphocytic leukaemia
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing
Venous thromboembolism in adults
Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism
Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal)
Vernakalant for the rapid conversion of recent onset atrial fibrillation to sinus rhythm (terminated appraisal)
Vertebral body tethering for idiopathic scoliosis in children and young people
VEST external stent for coronary artery bypass grafts
Vibegron for treating symptoms of overactive bladder syndrome
VibraTip for testing vibration perception to detect diabetic peripheral neuropathy
VIDAvision for lung volume analysis in emphysema
Video laryngoscopes to help intubation in people with difficult airways
ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesions
Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract
Violence and aggression: short-term management in mental health, health and community settings
Violent and aggressive behaviours in people with mental health problems
Virtual chromoendoscopy to assess colorectal polyps during colonoscopy
Virtual reality technologies for treating agoraphobia or agoraphobic avoidance: early value assessment
Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C
Virtual ward platform technologies for acute respiratory infections: early value assessment
Visensia for early detection of deteriorating vital signs in adults in hospital
Vismodegib for treating basal cell carcinoma
Vitamin B12 deficiency in over 16s: diagnosis and management
Vitamin D: supplement use in specific population groups
VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions
Voclosporin with mycophenolate mofetil for treating lupus nephritis
Volanesorsen for treating familial chylomicronaemia syndrome
Vorasidenib for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after surgery in people 12 years and over
Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutations
Vortioxetine for treating major depressive episodes
Vutrisiran for treating hereditary transthyretin-related amyloidosis
Vutrisiran for treating transthyretin amyloidosis with cardiomyopathy
VA ECMO for postcardiotomy cardiogenic shock in adults
VA ECMO for severe acute heart failure in adults
VAAFT for treating anal fistulae
Vaccine uptake in the general population
Vaccine uptake in under 19s
Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease
Vaginal transluminal endoscopic hysterectomy and adnexal surgery for benign gynaecological conditions
Valve-in-valve TAVI for aortic bioprosthetic valve dysfunction
Vamorolone for treating Duchenne muscular dystrophy in people 4 years and over
Vandetanib for treating medullary thyroid cancer
Vanzacaftor-tezacaftor-deutivacaftor for treating cystic fibrosis with 1 or more F508del mutations in the CFTR gene in people 6 years and over
Varenicline for smoking cessation
Varicose veins in the legs
Varicose veins: diagnosis and management
Vedolizumab for treating chronic refractory pouchitis after surgery for ulcerative colitis (terminated appraisal)
Vedolizumab for treating moderately to severely active Crohn's disease after prior therapy
Vedolizumab for treating moderately to severely active ulcerative colitis
Velmanase alfa for treating alpha-mannosidosis
Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation‑positive malignant melanoma
Venetoclax for treating chronic lymphocytic leukaemia
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable
Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia
Venetoclax with rituximab for previously treated chronic lymphocytic leukaemia
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing
Venous thromboembolism in adults
Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism
Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal)
Vernakalant for the rapid conversion of recent onset atrial fibrillation to sinus rhythm (terminated appraisal)
Vertebral body tethering for idiopathic scoliosis in children and young people
VEST external stent for coronary artery bypass grafts
Vibegron for treating symptoms of overactive bladder syndrome
VibraTip for testing vibration perception to detect diabetic peripheral neuropathy
VIDAvision for lung volume analysis in emphysema
Video laryngoscopes to help intubation in people with difficult airways
ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesions
Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract
Violence and aggression: short-term management in mental health, health and community settings
Violent and aggressive behaviours in people with mental health problems
Virtual chromoendoscopy to assess colorectal polyps during colonoscopy
Virtual reality technologies for treating agoraphobia or agoraphobic avoidance: early value assessment
Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C
Virtual ward platform technologies for acute respiratory infections: early value assessment
Visensia for early detection of deteriorating vital signs in adults in hospital
Vismodegib for treating basal cell carcinoma
Vitamin B12 deficiency in over 16s: diagnosis and management
Vitamin D: supplement use in specific population groups
VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions
Voclosporin with mycophenolate mofetil for treating lupus nephritis
Volanesorsen for treating familial chylomicronaemia syndrome
Vorasidenib for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after surgery in people 12 years and over
Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutations
Vortioxetine for treating major depressive episodes
Vutrisiran for treating hereditary transthyretin-related amyloidosis
Vutrisiran for treating transthyretin amyloidosis with cardiomyopathy